BioNTechBNTX

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid.

Ratings

3 / 5

1 rating in the last 12 months

5
4
3
2
1
CEO
Professor Ugur Sahin, M.D.

$22.3B

Market Cap • 20/05/2024

2008

(há 16 anos)
Fundação

2019

(5 years ago)
IPO

NASDAQ

Listagem
Flag of DE

Mainz

Sede • RP

4.530

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

BNTXSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

2%

1 dia

17/05/2024

-0%

1 semana

13/05/2024

5%

1 mês

22/04/2024

-14%

1 ano

22/05/2023

10 anos

Histórico